ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Patrick J Heron bought $86K of Arcutis Biotherapeutics, Inc.
Bought$85,691
$13.60Price
6,300Shares
What ARQT did for a copier
- $1,000 copied at Wed, May 14 open, $13.94
- $986
- S&P 500, same days
- +4.9%
Measured over 30 trading days, to the Jun 27 close.
Patrick J Heron's record
15 other buys with 3 months of prices since 2020: on average +5.9% against the S&P 500, and 9 of 15 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, May 9. Filed Tue, May 13, 4:11 PM ET, after the close. Returns use the May 14 open and the Jun 27 close. Not investment advice.